Hostname: page-component-76d6cb85b7-hqrjx Total loading time: 0 Render date: 2026-07-18T03:31:55.780Z Has data issue: false hasContentIssue false
  • English
  • Français

Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment

Published online by Cambridge University Press:  09 January 2023

Maiss Ahmad Open the ORCID record for Maiss Ahmad [Opens in a new window] ,
Kasem S. Akhras  and
Shadi Saleh
Maiss Ahmad*
Affiliation:
Faculty of Business and Law, The British University in Dubai, Dubai, UAE
Kasem S. Akhras
Affiliation:
UIC College of Pharmacy, Chicago, IL, USA
Shadi Saleh
Affiliation:
Global Health Institute, American University of Beirut, Beirut, Lebanon
*
*Author for correspondence: Maiss Ahmad, E-mails: maiss-ahmad@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

The launch of innovative technologies has been credited with significant improvements in health indicators, but it comes at a high financial impact, and the value of certain innovations may not be well documented. Health technology assessment (HTA) is a universally established process to assess the incremental value of innovations. Despite its acknowledged value, almost one-third of the countries around the globe have not established yet a formal HTA in their health systems. The UAE is one of the pioneering countries worldwide in adopting innovative health technologies. This emphasizes the importance of exploring the key elements in the UAE’s journey toward the establishment of HTA. Our study aims to articulate an academic insight that can support the ongoing endeavors to establish the HTA in the UAE. This case study was guided by an analytical framework. Data was collected from document review and semistructured interviews, then analyzed by applying the codebook thematic analysis technique. The findings outline multiple facilitators and challenges in the perspective process, as they show a multidimensional interlink between all identified elements. Markedly, leveraging the role of specialized academia and building HTA genuine knowledge are the areas that need the most attention. The originality of this research is associated with analyzing the three health policy pillars: the context, actors, and content in a prospective HTA establishment process. The main practical implications generated from this study are supporting global health organizations, HTA policy entrepreneurs, and academics in improving their strategies and designing more effective HTA policy learning programs.

Keywords

HTAhealth policy analysishealth innovationsCOVID-19UAE

Information

Type
Policy
Information
International Journal of Technology Assessment in Health Care , Volume 39 , Issue 1 , 2023 , e3
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

O’Rourke, B, Oortwijn, W, Schuller, T. The new definition of health technology assessment. Value Health. 2020;23(6):824–825.CrossRefGoogle ScholarPubMed
Banta, D. Perspective: Some conclusions from my life in health technology assessment. Int J Technol Assess Health Care. 2018;34(2):131–133.CrossRefGoogle ScholarPubMed
Rashidian, A, Mandil, A, Mahjour, J. Improving evidence informed policy-making for health in the eastern Mediterranean region (editorial). East Mediterr Health J. 2018;23(12):793–794.CrossRefGoogle ScholarPubMed
Kristensen, FB, Lampe, K, Wild, C, et al. The HTA Core Model®—10 years of developing an international framework to share multidimensional value assessment. Value Health. 2017;20(2):244–250.CrossRefGoogle ScholarPubMed
Kim, T, Sharma, M, Teerawattananon, Y, et al. Addressing challenges in health technology assessment institutionalization for furtherance of universal health coverage through south-south knowledge exchange: Lessons from Bhutan, Kenya, Thailand, and Zambia. Value Health Reg Issues. 2021;24:187–192.CrossRefGoogle ScholarPubMed
Liu, G, Wu, EQ, Ahn, J, et al. The development of health technology assessment in Asia: Current status and future trends. Value Health Reg Issues. 2020;21(C):39–44.CrossRefGoogle ScholarPubMed
Hasan, SS, Kow, CS, Dawoud, D, Baines, D, Z-U-D, Babar. Pharmaceutical policy reforms to regulate drug prices in Asia Pacific Region: The case of Australia, China, India, Malaysia, New Zealand and South Korea. Value Health Reg Issues. 2019;(18):18–23.CrossRefGoogle Scholar
Kanavos, P, Kamphuis, BW, Fontrier, AM, et al, . Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally? Health Policy. 2020;124(12):1297–1309.CrossRefGoogle ScholarPubMed
U.S.-U.A.E. Business Council. US-UAE Business Council Health Sector report. 2019, pp. 1–68. Available from: http://usuaebusiness.org/wp-content/uploads/2019/01/2019-Healthcare-Report.pdf.Google Scholar
Alrahbi, D, Khan, M, Hussain, M. Exploring the motivators of technology adoption in healthcare. Int J Healthc Manag. 2021;14(1):50–63.CrossRefGoogle Scholar
UAE’s MoF. UAE’s Ministry of Finance official website. 2021.Google Scholar
The World Bank. The World Bank—UAE’s health expenditure. 2021. Available from: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=AE.Google Scholar
Al-Utaibi, G. Predicting future health demands in United Arab Emirates. Int J Psychosoc Rehabil. 2020;24(5):3385–3390.Google Scholar
Kapar, H, Mukadam, M, Mohamed, O. Health technology assessment in MEA pharmaceutical perspective. MEA (Middle East Africa) office: IQVIA; 2018, pp. 1–17.Google Scholar
Torbica, A. HTA around the world: Broadening our understanding of cross-country differences. Value Health. 2020;23(1):1–2.CrossRefGoogle ScholarPubMed
Löblová, O, Trayanov, T, Csanádi, M, Ozierański, P. The emerging social science literature on health technology assessment: A narrative review. Value Health. 2020;23(1):3–9.CrossRefGoogle ScholarPubMed
O’Brien, GL, Sinnott, SJ, Walshe, V, Mulcahy, M, Byrne, S. Health policy triangle framework: Narrative review of the recent literature. Health Policy OPEN. 2020;1(3):100016.CrossRefGoogle Scholar
King, O. Two sets of qualitative research reporting guidelines: An analysis of the shortfalls. Res Nurs Health. 2021;44(4):715–723.CrossRefGoogle ScholarPubMed
Braun, V, Clarke, V. Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Couns Psychother Res. 2021;21(1):37–47.CrossRefGoogle Scholar
UAE Government. About UAE. 2021. Available from: https://u.ae/en/about-the-uae.Google Scholar
World Population Review. United Arab Emirates population 2021. 2021. Available from: https://worldpopulationreview.com/countries/united-arab-emirates-population.Google Scholar
Najib, D. COVID-19 and the Arab world-between a rock and hard place. Sci Dipl. 2021;10:1–7.Google Scholar
Lorgelly, P. Impact of COVID-19 pandemic on HTA. PharmacoEconomics Outcomes News. 2020;853(1):2–2.CrossRefGoogle Scholar
Mukherjee, K. Integrating technology, innovation and policy: COVID-19 and HTA. Health Policy Technol. 2021;10(1):16–20.CrossRefGoogle Scholar
Franco-Trigo, L, Fernandez-Llimos, F, Martínez-Martínez, F, Benrimoj, SI, Sabater-Hernández, D. Stakeholder analysis in health innovation planning processes: A systematic scoping review. Health Policy. 2020;124(10):1083–1099.CrossRefGoogle ScholarPubMed